Global Infertility Market Size, Insights, Drug Development, Infertility Treatment, Technology Trends, Key Players, SWOT analysis, Industry Growth, Forecast to 2023

Global Infertility Market Size, Analysis By Drugs (Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment And Others), By Techniques (Assisted Reproductive Technology (Art), Intrauterine Insemination, And Surgery (Laparoscopic Or Hysteroscopic Surgery, Tubal Surgeries And Others) And Others) - Forecast To 2023

The global infertility market is increasing progressively, mainly due to the presence of proper regulatory frameworks that have helped assisted reproduction technologies to gain quick acceptance in developed as well as developing regions, globally. These fertility technologies have garnered tremendous popularity and, are perceiving an upsurge demand, worldwide. As a result, over the past couple of decades, the infertility market is garnering more attention on the global platform.

Considering the phenomenal accruals, the market is continuously gaining; Market Research Future (MRFR), in its recently published study report asserts that the global Infertility market is set to witness a sound growth by 2023, registering approximately 4.6% CAGR throughout the forecast period (2017 – 2023).

Additional factors like the growing prevalence of infertility and gynecological disorders that are increasing every year are positively impacting market growth. Moreover, factors such as the increasing issue of infertility predominantly led by the hectic schedule, heady lifestyles, stress, and tension coupled with the other health deteriorating reasons are accelerating the growth of the market, increasing need of fertilization procedures.

Furthermore, the government funding alongside the demand for pre-identification of genetic disorders led by the various technological revolutions is fostering the market growth, pervasively. Also, factors such as the increasing technological advancement in healthcare and increasing development in biological substitutes are further enhancing the growth of the infertility market, globally.

On the flip side, factors such as the availability of paradox of choices that are offering too many options in the market and low adoption of these technologies in countries having inherent potential are anticipated to obstruct the growth of the infertility market during the forecast period.

Request Free Sample @

Global Infertility Market – Segments

For ease of understanding, the market has been segmented into five key dynamics: -

By Sex: Males, Females and Unexplained.

By Diagnosis: Men Diagnostic Tests (Semen Analysis, Genetic Testing, Testicular Biopsy, and other), Women Diagnostic Tests (Hysteroscopy, Laparoscopy, Ovulation Testing, Hysterosalpingography, and others.) and General Diagnostic Tests (Genetic Testing, Hormone Testing, Microscopic Analysis, Imaging, and others). Among other tests.

By Drugs: Clomiphene Citrate, Letrozole, Serophene, and Hormone Treatment among others.

By Techniques: Assisted Reproductive Technology (ART), Intrauterine Insemination, and Surgeries (Laparoscopic or Hysteroscopic Surgery, Tubal Surgeries, and others) And Others) among others.

By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World.

Global Infertility Market - Regional Analysis

Well-developed regions such as North America and Europe, heading with their comparatively lower birth-rate account for the leading markets in the global infertility market. Also, various socioeconomic factors such as the financial support from the government for R&D in the field and R&D funding from private organizations to develop new techniques and technologies are predominantly increasing the size of the infertility market in these regions.

The US backed by the increasing pool of awareness, high income, and good reimbursement scenario accounts for the maximum market share in the North American infertility market. Whereas, countries such as the UK, Germany, and Canada are also expected to play an important role in the growth of this market.

North America holds a significantly larger share in the global infertility market, and, Europe is estimated to demonstrate high growth by the end of the forecast period, accounting for the second-largest market, globally.

The infertility market in the Asia Pacific region is quadrupling majorly due to the large technological advancements. Moreover, factors such as the rapid socio-ecological changes, the increasing number of working women populaces, and the rapidly improving economy are positively impacting the growth of the regional market. South Asian countries backed by the high rate of male infertility and the vast population with unmet needs are leading the APAC infertility market.

Global Infertility Market - Competitive Analysis

Highly competitive, the infertility market appears to be hugely fragmented with the presence of several large and small players. The key strategies traced from the analysis of recent market developments include agreement & partnership, product launch, acquisition, and expansion.

International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of technology portfolios, differentiation, quality, and pricing.

These key players are employing strategies of creating alliances with e-commerce partners and maintaining distribution agreements with strong local players in regions such as Western Europe and APEJ to consolidate their position.

Major Players:

Key players leading the global infertility market include SCSA Diagnostics, Inc., Halotech DNA, Andrology Solutions, Androvia LifeSciences, Zydus Cadila Healthcare Ltd, Aetna Inc., EMD Serono, Inc., and Bayer Healthcare among others.

Get full report & TOC @:

Industry/Innovation/Related News:

March 15, 2019 ---- A group from researchers from London presented their study of comparing the DNA integrity in infertile and fertile men, at the European Association of Urology Congress, held in Barcelona. These scientists have found that the DNA of sperm taken from the testicles of infertile men was as good as that of ejaculated sperm of fertile men.

This research explains a major cause of male infertility and opens up the possibility of using sperm taken directly from the testicles to overcome infertility among males. Infertility is a major public health issue across Europe, and male infertility is the biggest cause in couples seeking treatment.

As DNA integrity is believed to play a role in fertilization rates in assisted reproduction, these results may aid in the decision-making whether or not to resort to testicular biopsy/testicular sperm aspiration rather than using ejaculated sperm to enhance success rates of assisted fertilization in infertile men with signs of DNA damage.

However, these scientists also confirmed that they can't yet prove that this sperm DNA damage is the leading cause of male infertility or ART failure in these men, or that using testicular sperm directly would help improve their chance of getting pregnant, but the work certainly points in that direction.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312

Release ID: 501884